Acyclovir Export Market Intelligence: India's 358 Suppliers Shipping to 152 Countries — TransData Nexus 2026

Q: Who are the top acyclovir exporters from India?

The top acyclovir exporters from India are: 1. MYLAN LABORATORIES LIMITED — $57.3M (45.5% market share); 2. HETERO LABS LIMITED — $36.4M (28.9% market share); 3. AUROBINDO PHARMA LTD — $8.1M (6.4% market share); 4. ZYDUS LIFESCIENCES LIMITED — $4.3M (3.4% market share); 5. EUGIA PHARMA SPECIALITIES LIMITED — $4.0M (3.2% market share). Together they account for 87.4% of India's total acyclovir export value.

Q: What is the total export value of acyclovir from India?

The total export value of acyclovir from India is $126.0M USD, recorded across 5,956 shipment transactions from 358 active exporters to 152 destination countries. The average shipment value is $21.2K.

Q: Which countries import acyclovir from India?

India exports acyclovir to 152 countries worldwide. The top importing countries are: UNITED STATES (74.7% share, $94.1M), CANADA (11.8% share, $14.9M), TAIWAN (2.4% share, $3.0M), MOZAMBIQUE (1.9% share, $2.4M), SWEDEN (1.5% share, $1.9M). These five markets account for 92.3% of total export value.

Q: What is the HS code for acyclovir exports from India?

The primary HS code for acyclovir exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of acyclovir exports from India?

The average unit price for acyclovir exports from India is $4.13 USD per unit, with prices ranging from $0.00 to $3407.51 depending on formulation, packaging, and order volume. The total market is valued at $126.0M across 5,956 shipments.

Q: Which ports handle acyclovir exports from India?

The primary ports for acyclovir exports from India are SAHAR AIR CARGO ACC (INBOM4) (21.1% of shipments), DELHI AIR CARGO ACC (INDEL4) (15.7% of shipments), SAHAR AIR (14.7% of shipments), DELHI AIR (10.3% of shipments), Bombay Air (4.2% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of acyclovir?

India is one of the world's leading exporters of acyclovir due to its large base of 358 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports acyclovir to 152 countries, demonstrating 78% global market coverage.

Q: What certifications do Indian acyclovir exporters need?

Indian acyclovir exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import acyclovir from India?

There are 879 registered buyers importing acyclovir from India, spread across 152 countries. The repeat buyer rate is 48.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top acyclovir supplier from India?

MYLAN LABORATORIES LIMITED is the leading acyclovir exporter from India with a market share of 45.5% and total export value of $57.3M across 83 shipments. The top 5 suppliers together control 87.4% of total export value.

Suresh Sormare

Acyclovir

India Pharmaceutical Trade Intelligence

$126.0M358 Suppliers152 CountriesHS 30049099

ExportsIndia → UNITED STATES74.7%India → CANADA11.8%

ImportsUNITED STATES → India$95.7K CANADA → India$17.8K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Acyclovir Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Acyclovir to the World

Between 2022 and 2026, India exported $126.0M worth of acyclovir across 5,956 verified shipments to 152 countries — covering 78% of world markets in the Antivirals segment. The largest destination is UNITED STATES (74.7%). MYLAN LABORATORIES LIMITED leads with a 45.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Acyclovir export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Acyclovir export data snapshot — $126.0M · 358 exporters · 152 countriesTransData Nexus · Indian Customs Data

Top Acyclovir Exporters from India

358 active exporters · Ranked by export value

View all 358 →

Top Acyclovir Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MYLAN LABORATORIES LIMITED	$57.3M	83	3	45.5%
2	HETERO LABS LIMITED

Top Countries Importing Acyclovir from India

152 destination markets · Ranked by import value

All 152 countries →

Top Countries Importing Acyclovir from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$94.1M	74.7%
2	CANADA	$14.9M	11.8%
3	TAIWAN	$3.0M	2.4%
4	MOZAMBIQUE	$2.4M	1.9%
5	SWEDEN	$1.9M	1.5%
6	RUSSIA	$1.5M	1.2%
7	SOUTH AFRICA	$1.1M	0.9%
8	SAUDI ARABIA	$614.5K	0.5%
9	AUSTRALIA	$592.1K	0.5%
10	CHILE	$574.9K	0.5%

UNITED STATES is India's largest acyclovir export destination, absorbing 74.7% of total exports worth $94.1M. The top 5 importing countries — UNITED STATES, CANADA, TAIWAN, MOZAMBIQUE, SWEDEN — together account for 92.3% of India's total acyclovir export value. The remaining 147 destination countries collectively receive the other 7.7%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Acyclovir to India?

8 origin countries · Total import value: $134.1K

India imports acyclovir from 8 countries with a combined import value of $134.1K. The largest supplier is UNITED STATES ($95.7K, 52 shipments), followed by CANADA and IRAQ. All values are from Indian Customs (DGFT) import records.

Countries Supplying Acyclovir to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$95.7K	52	71.3%
2	CANADA	$17.8K	17	13.3%
3	IRAQ	$10.5K	1	7.8%
4	GERMANY	$3.4K	2	2.6%
5	AUSTRALIA	$2.5K	5	1.9%
6	ITALY	$2.0K	1	1.5%
7	BULGARIA	$1.6K	2	1.2%
8	SOUTH AFRICA	$599	11	0.4%

UNITED STATES is the largest supplier of acyclovir to India, accounting for 71.3% of total import value. The top 5 origin countries — UNITED STATES, CANADA, IRAQ, GERMANY, AUSTRALIA — together supply 96.9% of India's acyclovir imports. Click any country to see detailed supplier and buyer data for that import corridor.

Acyclovir — Export Intelligence Video

Visual overview of India's acyclovir import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's acyclovir pharmaceutical import and export market — $126.0M in total trade, 358 verified manufacturers, and 152 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Acyclovir

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Acyclovir, an antiviral medication, has been a staple in the U.S. pharmaceutical market for decades. The FDA's Orange Book lists numerous approved Abbreviated New Drug Applications (ANDAs) for acyclovir, indicating a well-established generic presence. Notably, the first generic approvals date back to the late 1980s, underscoring the drug's long-standing availability. The absence of recent first generic approvals suggests market saturation.

Regarding import alerts, as of March 2026, there are no specific FDA import alerts targeting acyclovir products from India. This indicates that Indian manufacturers have maintained compliance with FDA standards, facilitating uninterrupted exports to the U.S. market. Given that 74.7% of India's acyclovir exports are destined for the United States, this compliance is crucial for sustaining trade relations.

2EU & UK Regulatory Framework

In the European Union, acyclovir is authorized through national procedures, with marketing authorizations granted by individual member states. The European Medicines Agency (EMA) oversees harmonization efforts to ensure consistent safety and efficacy standards across the EU. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates acyclovir, ensuring compliance with national guidelines. Manufacturers exporting to these regions must adhere to Good Manufacturing Practice (GMP) requirements as outlined by the EMA and MHRA, which encompass stringent quality control measures and regular inspections.

3WHO Essential Medicines & Global Standards

Acyclovir is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. The drug is also subject to international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards ensures the quality, safety, and efficacy of acyclovir products worldwide.

4India Regulatory Classification

In India, acyclovir is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, acyclovir is not listed under the Drug Price Control Order (DPCO), allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national and international regulations.

5Patent & Exclusivity Status

The primary patents for acyclovir have long expired, leading to a robust generic market with significant competition. This competitive landscape has contributed to the drug's affordability and widespread availability.

6Recent Industry Developments

In June 2025, the NPPA conducted a review of antiviral drug prices, including acyclovir, to assess market dynamics and ensure fair pricing. In September 2025, the CDSCO issued updated guidelines for the export of pharmaceutical products, emphasizing stricter quality control measures to align with international standards. In December 2025, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of acyclovir, highlighting its continued relevance in treating viral infections.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Acyclovir

Retail & reference prices across 9 markets vs. India FOB export price of $4.13/unit

Global Price Benchmark for Acyclovir across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$2.50	USD	According to the FDA's Orange Book, Acyclovir is an approved antiviral medication.
United Kingdom	$2.30	GBP	The NHS Drug Tariff lists Acyclovir as a reimbursable medication.
Germany	$2.20	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) includes Acyclovir in its list of approved medications.
Australia	$2.10	AUD

Supply Chain Risk Assessment — Acyclovir

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, often referred to as the "pharmacy of the world," heavily relies on China for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). Approximately 70% of India's API and KSM requirements are imported from China, creating a significant dependency. This reliance exposes the supply chain to vulnerabilities, as any disruption in Chinese exports can lead to shortages and increased costs for Indian manufacturers.

Efforts to reduce this dependency have been initiated through the Production Linked Incentive (PLI) scheme, launched in October 2024, aiming to bolster domestic production of critical APIs and KSMs. Two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and Clavulanic Acid, which had not been produced domestically for over two decades. Despite these initiatives, challenges such as cost competition from Chinese manufacturers, who have reportedly slashed prices of certain APIs by up to 50% in September 2025, continue to undermine India's self-sufficiency efforts.

2Supplier Concentration & Single-Source Risk

The export data for Acyclovir from India indicates a high supplier concentration, with the top five exporters accounting for 87.4% of the total export value. Notably, MYLAN LABORATORIES LIMITED alone holds a 45.5% share, amounting to $57.3 million USD. This concentration poses a significant single-source risk, as any operational or regulatory issues affecting these key suppliers could disrupt the entire supply chain.

Access Complete Acyclovir Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 5,956 transactions across 152 markets.

Request Demo View Pricing

Frequently Asked Questions — Acyclovir Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top acyclovir exporters from India?

The leading acyclovir exporters from India are MYLAN LABORATORIES LIMITED, HETERO LABS LIMITED, AUROBINDO PHARMA LTD, and 12 others. MYLAN LABORATORIES LIMITED leads with 45.5% market share ($57.3M). The top 5 suppliers together control 87.4% of total export value.

What is the total export value of acyclovir from India?

The total export value of acyclovir from India is $126.0M, recorded across 5,956 shipments from 358 active exporters to 152 countries. The average shipment value is $21.2K.

Which countries import acyclovir from India?

India exports acyclovir to 152 countries. The top importing countries are UNITED STATES (74.7%), CANADA (11.8%), TAIWAN (2.4%), MOZAMBIQUE (1.9%), SWEDEN (1.5%), which together account for 92.3% of total export value.

What is the HS code for acyclovir exports from India?

The primary HS code for acyclovir exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Acyclovir

Acyclovir

Top Acyclovir Exporters from India

Top Countries Importing Acyclovir from India

Who Supplies Acyclovir to India?

Quick Facts

Related Antivirals

Related Analysis

Need Details?

Acyclovir — Export Intelligence Video

Regulatory Landscape — Acyclovir

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Acyclovir

Supply Chain Risk Assessment — Acyclovir

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Acyclovir Trade Intelligence

Frequently Asked Questions — Acyclovir Exports from India

Who are the top acyclovir exporters from India?

What is the total export value of acyclovir from India?

Which countries import acyclovir from India?

What is the HS code for acyclovir exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of acyclovir exports from India?

Which ports handle acyclovir exports from India?

Why is India a leading exporter of acyclovir?

What certifications do Indian acyclovir exporters need?

How many buyers import acyclovir from India?

What is the market share of the top acyclovir exporter from India?

Analysis Methodology